Home LiteratureArticle Details
PMID: 14769624 Published · ppublish English Comparative Study Journal Article Multicenter Study Research Support, U.S. Gov't, P.H.S.

Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).

Archives of internal medicine ·Vol. 164 ·No. 3 ·2004-02-09 ·Pages 289-98

Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J

Abstract

Subclinical depression, often clinically unrecognized, may pose increased risk of cardiovascular disease. Few studies have prospectively investigated cardiovascular events related to depression in older women. We describe prevalence, cardiovascular correlates, and relationship to subsequent cardiovascular events of depressive symptoms among generally healthy postmenopausal women. The Women's Health Initiative Observational Study followed up 93 676 women for an average of 4.1 years. Depression was measured at baseline with a short form of the Center for Epidemiological Studies Depression Scale. Risks of cardiovascular disease (CVD) events were estimated from Cox proportional hazards models adjusting for multiple demographic, clinical, and risk factor covariates. Current depressive symptoms above the screening cutoff point were reported by 15.8% of women. Depression was significantly related to CVD risk and comorbidity (odds ratios ranging from 1.12 for hypertension to 1.60 for history of stroke or angina). Among women with no history of CVD, depression was an independent predictor of CVD death (relative risk, 1.50) and all-cause mortality (relative risk, 1.32) after adjustment for age, race, education, income, diabetes, hypertension, smoking, high cholesterol level requiring medication, body mass index, and physical activity. Taking antidepressant medications did not alter the depression-associated risks associated. A large proportion of older women report levels of depressive symptoms that are significantly related to increased risk of CVD death and all-cause mortality, even after controlling for established CVD risk factors. Whether early recognition and treatment of subclinical depression will lower CVD risk remains to be determined in clinical trials.

MeSH Terms
Aged Antidepressive Agents/administration & dosage,therapeutic use Cardiovascular Diseases/drug therapy,epidemiology,physiopathology Depression/drug therapy,epidemiology,physiopathology Dose-Response Relationship, Drug Estrogens/administration & dosage Exercise/physiology Female Follow-Up Studies Humans Life Style Middle Aged Motor Activity/physiology Postmenopause/physiology Predictive Value of Tests Prevalence Progesterone/administration & dosage Proportional Hazards Models Prospective Studies Racial Groups Risk Factors Statistics as Topic Survival Analysis Treatment Outcome United States/epidemiology Women's Health
Chemicals
Antidepressive Agents Estrogens Progesterone
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Wassertheil-Smoller Sylvia
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. [email protected]
Shumaker Sally
Ockene Judith
Talavera Greg A
Greenland Philip
Cochrane Barbara
Robbins John
Aragaki Aaron
Dunbar-Jacob Jacqueline
Article Info
Journal
Archives of internal medicine
Abbr.
Arch Intern Med
ISSN
0003-9926
Published
2004-02-09
Pages
289-98
Language
English
Region
United States
NLM ID
0372440
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]